MLH1 and neoplasm: We also investigated MSI and p53 and hMLH1 expression in the metachronous secondary gastric cancers; all secondary tumours arising from patients with the mutator/MSI-type EGC also showed MSI and loss of hMLH1 expression (data not shown).